This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: ORCL, MTB, COF

Stocks in this article: BLK COF HCBK LNKD MTB ORCL

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Assurant (AIZ) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Company is facing increased regulatory risk. $45 price target.

Armstrong World (AWI) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.

BB&T (BBT) downgraded at Guggenheim from Buy to Hold, Guggenheim said. Valuation call, based on a $34 price target.

Blackrock (BLK - Get Report) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, based on a $224 price target.

Capital One (COF - Get Report) upgraded at Guggenheim from Neutral to Buy, Guggenheim said. $67 price target. Recent acquisitions should add to earnings.

Cintas (CTAS) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $45 price target.

Cloud Peak Energy (CLD) downgraded to hold at TheStreet Ratings.

Edgewater Technology (EDGW) downgraded to hold at TheStreet Ratings.

Hudson City (HCBK - Get Report) rated new Buy at Compass Point. Valuation call, based on an $8.50 price target.

LinkedIn (LNKD - Get Report) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $135 price target. Estimates also boosted, given higher operating metrics.

Allscripts (MDRX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Performance has lagged since the Eclipsys merger.

MicroStrategy (MSTR) rated new Buy at Think. $160 price target. License business is likely to show accelerated growth over the next couple of years.

M&T Bank (MTB) downgraded at Guggenheim from Buy to Neutral, Guggenheim said. $96 price target. Company is less attractive in an improving economy.

Nisource (NI) upgraded at Keybanc from Hold to Buy, Keybanc said. $26.50 price target. Stock is attractive, based on a sum-of-the-parts valuation.

Regions Financial (RF) upgraded at Guggenheim from Neutral to Buy, Guggenheim said. Valuation call, based on a $9 price target.

Royal Gold (RGLD) upgraded at National Bank Financial to Outperform from Sector Perform, National Bank Financial. $82 price target. Recent sell off overdone.

Silicon Laboratories (SLAB) upgraded at UBS to Buy from Neutral, UBS said. $50 price target. Expect new CEO to raise R&D efficiency.

US Silica (SLCA) rated new Buy at Dahlman. $25 price target. Company is leveraged to growth in the fracture proppant market.

Suntrust (STI) downgraded at Guggenheim from Buy to Neutral, Guggenheim said. Valuation call, based on a $26 price target.

STOCK COMMENTS / EPS CHANGES

Amedisys (AMED) numbers raised at Jefferies. Shares of AMED now seen reaching $16.50, Jefferies said. Estimates also raised to reflect benefit of agency rationalization efforts. Hold rating.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs